THE METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE®) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENT

Metabolic Conversion of Primidone (Mysoline) to Phenobarbital.

1956 • 69 citations

N‐mythelated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy

1958 • 47 citations

THE EVALUATION OF “MYSOLINE”—A NEW ANTICONVULSANT DRUG

1953 • 43 citations

Relative Anticonvulsant Potency of Primidone

1966 • 34 citations

Primidone (Mysoline) in the Treatment of Epilepsy

1956 • 21 citations

A Note on A Urinary Metabolite of Phenobarbitone

1955 • 15 citations

PRIMIDONE IN THE TREATMENT OF NON-IDIOPATHIC EPILEPSY

1954 • 15 citations

MYSOLINE IN THE TREATMENT OF EPILEPSY

1953 • 14 citations

Effects of Liver Damage and Nephrectomy on Anticonvulsant Activity of Mysoline and Phenobarbital*

1954 • 9 citations

REPORT ON “MYSOLINE” IN THE TREATMENT OF MENTAL HOSPITAL EPILEPTICS

1953 • 6 citations

[Clinical experiences with the antiepileptic mylepsin].

1956 • 2 citations

Treatment of epilepsy with mysoline.

1956 • 2 citations

Erfahrungen mit Mylepsin¹in der Epilepsiebehandlung

1956 • 2 citations

[Treatment of epilepsy with mysoline].

1956 • 1 citations

Experience with mylepsin in the management of epilepsy

1956 • 1 citations

Use of mysoline in barbiturate withdrawal.

1956 • 1 citations

Deleted Work

1955 • 0 citations